Related references
Note: Only part of the references are listed.Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation
Kyota Fukazawa et al.
Annals of Transplantation (2015)
Central pontine myelinolysis: A case report and clinical-pathological review
Rosa Cui et al.
PEDIATRIC TRANSPLANTATION (2012)
Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients
Maria-Sole Basso et al.
PEDIATRIC TRANSPLANTATION (2011)
Risk Factors for Central Pontine and Extrapontine Myelinolysis following Orthotopic Liver Transplantation
Eun Mi Lee et al.
EUROPEAN NEUROLOGY (2009)
Neurological complications of liver transplantation in pediatric patients: A single center experience
Ilknur Erol et al.
PEDIATRIC TRANSPLANTATION (2007)
Sirolimus as the main immunosuppressant in the early postoperative period following liver transplantation: a report of six cases and review of the literature
Marco Vivarelli et al.
TRANSPLANT INTERNATIONAL (2006)
Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation
B Forgacs et al.
TRANSPLANTATION PROCEEDINGS (2005)
Possible causes of central pontine myelinolysis after liver transplantation
Jun Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients
BV Maramattom et al.
NEUROLOGY (2004)
Axonal damage: a key predictor of outcome in human CNS diseases
IM Medana et al.
BRAIN (2003)
Subclinical central pontine myelinolysis following liver transplantation
T Kato et al.
BRAIN & DEVELOPMENT (2002)
Experience with the use of sirolimus in liver transplantation - Use in patients for whom calcineurin inhibitors are contraindicated
GJ Chang et al.
LIVER TRANSPLANTATION (2000)
Subclinical central pontine myelinolysis after liver transplantation
CC Lui et al.
TRANSPLANTATION PROCEEDINGS (2000)
Share Paper
